Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Jul 1, 2016
Insider Transaction Report
Form 4
Farrell Geraldine T
VP Operations, General Counsel
Transactions
- Exercise/Conversion
Ordinary Shares
2016-07-01$0.13/sh+2,867$358→ 24,120 total(indirect: By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Famil A/C>) - Exercise/Conversion
Ordinary Shares
2016-07-01$0.13/sh+2,340$293→ 6,640 total - Exercise/Conversion
Options to Purchase Shares
2016-07-01−2,867→ 2,866 total(indirect: By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>)Exercise: $0.13Exp: 2019-07-01→ Ordinary Shares (2,867 underlying) - Exercise/Conversion
Restricted Share Units
2016-07-01−2,340→ 7,018 totalExercise: $0.13Exp: 2020-07-01→ Ordinary Shares (2,340 underlying)
Footnotes (3)
- [F1]The reporting person and her spouse have shared voting and dispositive power with respect to these reported securities.
- [F2]The remaining 2,866 options will vest and become exercisable on 7/1/17.
- [F3]2,340 of the Restricted Share Units shall vest and become convertible on 7/1/17 and 2,339 of the Restricted Share Units shall vest and become convertible on each of 7/1/18 and 7/1/19, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.